ABSTRACT
INTRODUCTION
Identification of viable myocardium in patients with ischemic cardiomyopathy is of great clinical importance, as patients with evidence of myocardial viability will benefit from revascularization 1 .
Delayed contrast-enhanced magnetic resonance imaging (DCE MRI) is a well-established tool for myocardial viability testing. It visualizes injured myocardium with high spatial resolution 2 . Several studies have demonstrated effectiveness of this technique in predicting functional recovery after revascularization in patients with chronic ischemic left ventricular (LV) dysfunction [3] [4] [5] [6] .
The perfusable tissue index (PTI) is an alternative method for detection of myocardial viability [7] [8] [9] [10] [11] . PTI reflects the fraction of the myocardium that is able to exchange water rapidly, i.e. perfusable by water. PTI is a positron emission tomography (PET) derived index, in which the water perfusable tissue fraction (PTF) is related to the anatomic tissue fraction (ATF). Assuming the non-perfused fraction to be scar tissue, the reduction of PTI is a measure of the extent of damaged myocardium. Dysfunctional myocardium with normal or near normal PTI is expected to be viable because the amount of scar tissue is limited. In contrast, dysfunctional myocardium with a significant reduced PTI is less likely to be viable because more scar tissue is present.
In a previously published report 12 we demonstrated that PTI is inversely related to the extent of scar tissue, estimated by DCE-MRI, in patients with chronic ischemic LV dysfunction. A PTI cutoff value of 0.89 yielded the best diagnostic accuracy for detection of myocardial viability, when taking DCE-MRI as a reference. However, recovery of myocardial function after revascularization was not assessed. This cutoff value of 0.89 is distinctly higher than the optimal threshold of 0.70 observed in prior studies 7;8;10 .
Therefore, our aim was to compare PTI as a viability marker with DCE-MRI in patients with chronic ischemic cardiomyopathy, using functional recovery after revascularization (measured by MRI) as a reference to establish the diagnostic accuracy of PTI as a viability marker and determine the optimal cutoff value.
METHODS

Patient population
Fourteen patients with chronic ischemic LV dysfunction, who were scheduled to undergo surgical or percutaneous revascularization, were included. They underwent PET and baseline MRI one month before and follow-up MRI six months after revascularization.
Exclusion criteria were any absolute or relative contraindication to PET or MRI (e.g.
pacemaker, claustrophobia, atrial fibrillation). Baseline characteristics of the patient population are given in Table 1 . The protocol was approved by the Medical Ethics
Committee of the VU University Medical Center, and all patients gave written informed consent.
Percutaneous coronary intervention (PCI) was performed in half of the patients. Complete revascularisation was defined as revascularisation of all major epicardial vessels or first generation side branches with >50% diameter stenosis. For patients in whom revascularisation was incomplete, only segments in revascularized coronary artery territories were considered. All patients were in stable clinical condition at the time of the imaging and there was no clinical evidence of ischemic events in the period between the different examinations and revascularization. 
Imaging protocols
Positron Emission Tomography. All scans were performed in 2D mode, using an ECAT EXACT HR+ (Siemens/CTI, Knoxville, Tenn., USA). The scanning protocol was identical to that described previously 13 . Briefly, after a transmission scan, 1100 MBq of H 2 15 O was injected intravenously as a bolus injection. A dynamic scan was acquired for duration of 10 minutes. During a two minute period subjects inhaled at least 2000 MBq of C 15 O and a single frame was acquired for duration of 6 minutes, starting one minute after the end of inhalation to allow for equilibration in the blood pool. During the C 15 O scan three venous blood samples were drawn from the intravenous line and counted in a sodium iodide wellcounter cross calibrated against the scanner.
Magnetic Resonance Imaging. Magnetic resonance imaging was performed on a 1.5 Tesla scanner (Sonata, Siemens, Erlangen, Germany), using a four-element phased-array body radiofrequency receiver coil. All images were acquired with electrocardiogram gating and during repeated breath-holds of 10 to 15 seconds, depending on heart rate. After localizing scouts, cine images were acquired using a segmented steady-state-free precession sequence in three long axis views (two-, three, and four-chamber view) and in multiple short-axis views with a slice distance of 10 mm, covering the whole LV from base to apex. Scan parameters were: temporal resolution 34 ms, TR 3.0 ms. TE 1.5 ms, typical voxel size 1.4 X 1.8 X 5 mm 3 . Contrast-enhanced images were acquired 15 to 20 minutes after intravenous administration of 0.2 mmol/kg gadolinium-DTPA in the same view used as cine CMR, using a two-dimensional segmented inversion-recovery prepared gradient-echo sequence (TE 4.4 ms, TR 9.8 ms, inversion time 250 to 300 ms, typical voxel size 1.3 X 1.6 X 5 mm 3 ).
Data analysis
Positron Emission Tomography. Anatomical tissue fraction images were generated according to the procedure described by Iida et al 14 . Transaxial ATF images of the left ventricle were reoriented according to the anatomic axis of the heart and slices were displayed as short-axis slices. The same reslicing parameters were applied to the dynamic H 2 15 O images. ROIs were defined manually at the basal and midventricular level of the left ventricle as previously described. Corresponding ROIs from a variable number of slices were grouped in each patient to generate twelve volumes of interest (6 basal and 6 midventricular). The inferior volumes of interest were excluded from analysis because of anticipated perfusable tissue fraction spillover effects from the liver 13 .
Additional ROIs were defined in the left atrium and right ventricular chamber. 
Statistics
All data were expressed as mean ± SD. For comparison of two data sets, paired or unpaired Student's t tests were performed where appropriate. Comparison of multiple data sets was performed using analysis of variance (ANOVA), specific differences were identified by a Student's t test corrected for multiple comparisons with Bonferroni inequality adjustment.
Receiver operator characteristics (ROC) analysis for the differentiation between viable and nonviable segments by PTI and DCE was performed. Area under the ROC curve (AUC) was computed for both techniques. A p value < 0.05 was considered significant.
RESULTS
Fourteen patients completed the study protocol. All scans were of good quality.
Segmental analysis
One hundred and forty segments (10 segments per patient) were available for analysis. Fiftyfive segments were normokinetic at baseline, 39 of these segments showed no hyperenhancement and were considered control segments. Sixteen segments with normal wall thickening at baseline (3.7 ± 0.9 mm) showed contrast-enhancement (mean SEH 22 ± 20%), PTI in these segments was 1.03 ± 0.25. Eighty-five segments with wall thickening of less than 3 mm were considered dysfunctional at baseline. Baseline segmental PET and MRI data are summarized in Table 2 . There was a gradual decrease in PTI with increasing transmural extent of DCE (p < 0.001 by ANOVA). Receiver operator characteristics analysis of PTI and DCE MRI, predicting functional improvement after revascularization, is illustrated in Figure 1 . The AUC's of PTI en DCE MRI were 0.70 and 0.74, respectively. There was no significant statistical difference between the AUC's. Cut-off value of 25% SEH for prediction of functional recovery after revascularization allowed us to correctly identify 82% segments with and 64% segments without reversible dysfunction. A threshold of 0.89 for PTI yielded the best diagnostic accuracy with sensitivity and specificity values of 76% and 54%, respectively.
Global function
At follow-up there was a significant decrease of mean LV dimensions and a moderate improvement of LVEF. These data are summarized in Table 3 . 
DISCUSSION
The present study demonstrated that PTI can identify viable myocardium and predict improvement in regional function after revascularization in patients with chronic ischemic LV dysfunction. In agreement with our previous report 12 , the optimal PTI cut-off value equaled 0.89.
To date, only three studies have been published where functionally recoverable myocardium was identified using PTI before revascularization [8] [9] [10] . In two of these studies 8;10 , a cut-off value of 0.70 yielded the best diagnostic accuracy, which is distinctly lower than the optimal threshold of 0.89, found in the present study. By comparison, the lower cut-off of 0.70 was 98% sensitive, but only 24% specific, predicting functional recovery. In the third report by Gerber et al. 9 a PTI cut-off value of 0.90 yielded the best diagnostic accuracy with sensitivity of 75% and specificity of 86%. These findings are more in agreement with the results of the present study.
The specificity of PTI for prediction of functional improvement in this study equaled 54%, which is considerably lower than previous reports using PTI. This could be in part explained by a substantial number (31%) of presumably viable segments with no or minimal scar (< 25% SEH on DCE MRI) that did not improve after revascularization. On the other hand, PTI underestimates infarct size. PTI of normal myocardium should be close to unity.
Assuming the non-perfused fraction to be scar tissue, the reduction of PTI is a measure of the amount of damaged myocardium. This is supported by a gradual decrease in PTI with increasing transmural extent of hyperenhancement by DCE MRI. However, according to our data, PTI underestimates infarct size, given the fact that in segments with (near) transmural scar, PTI was 0.70 ± 0.11.
There were no significant statistical differences between PTI and DCE MRI techniques, when their accuracy in predicting segmental functional improvement was compared. The observed diagnostic accuracy is in agreement with pooled analysis of traditional viability imaging techniques 19 .
Limitations
This study has some limitations that should be acknowledged. First, a limited number of patients were evaluated. Second, data of several short axis slices were averaged to generate 6 basal and 6 midventricular segments. Although averaging of information obligatory causes some loss in detail, it may be less sensitive to misalignment that is always a potential source of error in follow-up studies. 
CONCLUSION
Perfusable tissue index can identify viable myocardium and predict improvement in regional function after revascularization in patients with chronic ischemic LV dysfunction. The best diagnostic accuracy for PTI was achieved using a cut-off value of 0.89.
